MediView

MediView is a MedTech company that leverages AR, telecollaboration, and data-driven insights to improve diagnostic imaging, surgical navigation, and clinical efficiencies. MediView's remote connectivity enables medical professionals to connect and collaborate remotely through shared communication, visualization, and holographic guidance. Moreover, MediView records the data generated during holographic procedures to provide insights to medical professionals. In addition, Mediview offers a training environment for students at sonography and echo programs, nursing schools, physician assistant schools, medical schools, and veterinary schools.

The company provides three solutions, MediScout (XR30), MediView XR50, and MediView XR90, at various stages of development. MediScout is a commercially available FDA Class I medical device, offering a collaborative and ergonomic ultrasound imaging solution. The XR50, to be submitted for FDA clearance, is an ultrasound imaging solution for needle-based procedures. The XR90, MediView's flagship product, is an FDA cleared imaging and navigation system for soft tissue and bone procedures, providing a clear view of the patient's internal anatomy via holographic surgical navigation (3D x-ray vision). In March 2024, a study published on the Journal of Medical Imaging found the XR90 accurate enough to carry out procedures with clinical precision.

Key customers and partnerships

MediView provides its solutions in partnership with GE Healthcare and Microsoft by integrating Microsoft's HoloLens 2 head-mounted display and GE's Vivid iq ultrasound system. In November 2022, Mediview collaborated with GE to develop the OmnifyXR Interventional Suite System, which is intended to improve ergonomics with natural interactions for optimum workflow and facilitate care team cooperation. In June 2024, MediView announced the first successful clinical use of the platform.

Funding and financials

In May 2023, the company raised USD 15 million in a strategic funding round with participation from Mayo Clinic, Cleveland Clinic, and GE HealthCare, among others. Funds were earmarked to create and enhance the company’s multi-level platform, prioritizing activities such as generating more clinical evidence, developing new products, protecting intellectual property, meeting regulatory requirements, achieving commercial goals, and launching new products.